Cargando…
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer
The p21-Activated kinase 1 (PAK1), a member of serine-threonine kinases family, was initially identified as an interactor of the Rho GTPases RAC1 and CDC42, which affect a wide range of processes associated with cell motility, survival, metabolism, cell cycle, proliferation, transformation, stress,...
Autores principales: | Yao, Dahong, Li, Chenyang, Rajoka, Muhammad Shahid Riaz, He, Zhendan, Huang, Jian, Wang, Jinhui, Zhang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449905/ https://www.ncbi.nlm.nih.gov/pubmed/32863957 http://dx.doi.org/10.7150/thno.46913 |
Ejemplares similares
-
Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer
por: Yao, Dahong, et al.
Publicado: (2020) -
Lotus seeds (Nelumbinis semen) as an emerging therapeutic seed: A comprehensive review
por: Arooj, Muzalfa, et al.
Publicado: (2021) -
The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target
por: Rammohan, Malini, et al.
Publicado: (2022) -
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
por: Yao, Dahong, et al.
Publicado: (2020) -
The Antiviral Effects of Jasminin via Endogenous TNF-α and the Underlying TNF-α-Inducing Action
por: Zhu, Xiaohong, et al.
Publicado: (2022)